Information on lobbying groups interested in promoting policies and funding for research and development of biotechnology, most notably Biotechnology Industry Organization (BIO). Includes information on lobby groups and lobbyists opposed to biotechnology funding and policies.
Information on lobbying groups interested in promoting policies and funding for research and development of biotechnology, most notably Biotechnology Industry Organization (BIO). Includes information on lobby groups and lobbyists opposed to biotechnology funding and policies.
Nature Medicine is the premier journal for biomedical research. Respected internationally for the quality of its papers on areas ranging from infectious disease to cancer and neurodegeneration.
Food and biotechnology companies opposed to mandatory labeling of foods that contain genetically modified food ingredients have disclosed expenditures of $63.6 million in 2014 to lobby for legislation that made reference to GMO labeling.
Biotechnology Industry Organization (BIO) is the world's largest biotechnology organization. Bio.org members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
Powerful farming and biotechnology interest groups announced Thursday they are banding together to push a federal voluntary labeling standard for genetically engineered food in an effort to stem the tide of state legislation seeking to mandate labeling.
The 50 biggest biotech and agrochemical trade groups spent over $572 million from 1999 to 2010 on lobbying. That's more than half a billion dollars! According to a new report from Food & Water Watch, the annual rate was a steady $30-$40 million per year until about 2006, when this industry apparently began courting Congress in earnest - as the annual figure nearly doubles between 2006 and 2010.
Things can get quite surreal in Brussels' EU quarter. On 22 January EuropaBio the biotech lobby hub organized an event to explain the consumer benefits of GMOs. But no consumer could possibly have learned about it: the event was confidential and no consumer group had been invited.
The battle over labeling GMO foods has prompted food companies to pour $27 million into lobbying efforts just in the last six months. With a lawsuit arguing that Vermont's GMO labeling law is unconstitutional and fights to stop labeling initiatives in other states, the big food lobbying push is likely to keep growing.
A new study has analyzed the lobbying activities of biotech companies and food patent holders since 1999. While the findings aren't surprising, they are enlightening as to why regulatory agencies and the U.S. Congress have shown the biotechnology industry such statutory favoritism.
Nature Medicine is the premier journal for biomedical research. Respected internationally for the quality of its papers on areas ranging from infectious disease to cancer and neurodegeneration.
Food and biotechnology companies opposed to mandatory labeling of foods that contain genetically modified food ingredients have disclosed expenditures of $63.6 million in 2014 to lobby for legislation that made reference to GMO labeling.
Biotechnology Industry Organization (BIO) is the world's largest biotechnology organization. Bio.org members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.
Powerful farming and biotechnology interest groups announced Thursday they are banding together to push a federal voluntary labeling standard for genetically engineered food in an effort to stem the tide of state legislation seeking to mandate labeling.
The 50 biggest biotech and agrochemical trade groups spent over $572 million from 1999 to 2010 on lobbying. That's more than half a billion dollars! According to a new report from Food & Water Watch, the annual rate was a steady $30-$40 million per year until about 2006, when this industry apparently began courting Congress in earnest - as the annual figure nearly doubles between 2006 and 2010.
Things can get quite surreal in Brussels' EU quarter. On 22 January EuropaBio the biotech lobby hub organized an event to explain the consumer benefits of GMOs. But no consumer could possibly have learned about it: the event was confidential and no consumer group had been invited.
The battle over labeling GMO foods has prompted food companies to pour $27 million into lobbying efforts just in the last six months. With a lawsuit arguing that Vermont's GMO labeling law is unconstitutional and fights to stop labeling initiatives in other states, the big food lobbying push is likely to keep growing.
A new study has analyzed the lobbying activities of biotech companies and food patent holders since 1999. While the findings aren't surprising, they are enlightening as to why regulatory agencies and the U.S. Congress have shown the biotechnology industry such statutory favoritism.